Back to search

Article

Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study

2023-06-01

Abstract excerpt

<h4>Background</h4> Tuberculosis (TB), a major cause of death in people living with HIV (PLHIV), remains challenging to diagnose. Diagnostic accuracy data are lacking for promising triage tests, such as C-reactive protein (CRP), and confirmatory tests, such as sputum and urine Xpert MTB/RIF Ultra (Ultra), and urine LAM, without prior symptom selection. <h4>Methods</h4> 897 PLHIV initiating antiretroviral therapy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e0b6a9a1-5438-579b-8be6-cd3a47e4bd92
DOI
10.1101/2023.05.30.23290716
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy studyDOI 10.1101/2023.05.30.23290716
Select a neighboring publication to make it the new centre.